RxDoctor Payments Data

Marco Ellis, MD

Plastic Surgery · Chicago, ILNPI 1508021171

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 89.9% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $92,846 and has fallen 51.0% since, to $45,452 in 2025. Among plastic surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$225,214in general payments, 2019–2025

Across 336 payments — averaging $670.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$203K
  • Zimmer Biomet$15K
  • Mentor Worldwide LLC$2K
  • Kerecis Limited$1K
  • Tepha Inc$816
  • Musculoskeletal Transplant Foundation Inc.$395
  • plus $3K from 19 others

What the payments were for

  • Consulting fees$91,53541%
  • Speaking & faculty fees$99,54444%
  • Travel & lodging$20,2729%
  • Food & beverage$13,8296%
  • Gifts$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$225,214 in reported general payments places this provider in the 95th percentile of 191 plastic surgery providers in Illinois.

See all plastic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$115,074
Medicare patients
97
Services billed
291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$58

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →